Published in Am J Med on September 01, 2013
Diabetes in older adults: a consensus report. J Am Geriatr Soc (2012) 3.63
Diabetes in older adults. Diabetes Care (2012) 3.62
High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes (2002) 2.98
Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation. J Allergy Clin Immunol (2011) 2.53
High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes (2002) 2.36
An official American Thoracic Society Workshop report: obesity and asthma. Proc Am Thorac Soc (2010) 2.05
Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation (2011) 1.81
The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep (2005) 1.66
Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. Atherosclerosis (2002) 1.60
Does addition of sitagliptin to metformin monotherapy improve glycemic control in patients with type 2 diabetes mellitus? Nat Clin Pract Endocrinol Metab (2007) 1.29
Obesity and asthma: an inflammatory disease of adipose tissue not the airway. Am J Respir Crit Care Med (2012) 1.28
Sex differences in the human brain's response to hunger and satiation. Am J Clin Nutr (2002) 1.25
Taste preferences and body weight changes in an obesity-prone population. Am J Clin Nutr (2004) 1.17
Treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin improves fasting islet-cell function in subjects with type 2 diabetes. J Clin Endocrinol Metab (2008) 1.09
Amyloid precursor protein expression is upregulated in adipocytes in obesity. Obesity (Silver Spring) (2008) 1.00
Comparison of the efficacy and tolerability profile of liraglutide, a once-daily human GLP-1 analog, in patients with type 2 diabetes ≥65 and <65 years of age: a pooled analysis from phase III studies. Am J Geriatr Pharmacother (2011) 0.97
Ezetimibe/simvastatin or atorvastatin for the treatment of hypercholesterolemia in patients with the metabolic syndrome: the VYMET study. Curr Diab Rep (2010) 0.96
Plasma amyloid-beta peptide levels correlate with adipocyte amyloid precursor protein gene expression in obese individuals. Neuroendocrinology (2009) 0.96
Adipose tissue dysfunction in polycystic ovary syndrome. Curr Diab Rep (2011) 0.95
Effect of ovarian suppression with gonadotropin-releasing hormone agonist on glucose disposal and insulin secretion. Am J Physiol Endocrinol Metab (2008) 0.95
Sexually dimorphic diet-induced insulin resistance in obese tissue inhibitor of metalloproteinase-2 (TIMP-2)-deficient mice. Endocrinology (2011) 0.90
The cannabinoid CB1 receptor is expressed in pancreatic delta-cells. Biochem Biophys Res Commun (2008) 0.90
Efficacy and safety of incretin-based therapies in patients with type 2 diabetes mellitus. Am J Med (2009) 0.90
Clinical measures of islet function: usefulness to characterize defects in diabetes. Curr Diabetes Rev (2008) 0.90
Advances in the treatment of prediabetes. Ther Adv Endocrinol Metab (2010) 0.89
Central and peripheral endocannabinoids and cognate acylethanolamides in humans: association with race, adiposity, and energy expenditure. J Clin Endocrinol Metab (2010) 0.86
Measurement of altered AβPP isoform expression in frontal cortex of patients with Alzheimer's disease by absolute quantification real-time PCR. J Alzheimers Dis (2012) 0.85
Endogenous glucose production, insulin sensitivity, and insulin secretion in normal glucose-tolerant Pima Indians with low birth weight. Metabolism (2004) 0.84
Sweet taste receptors regulate basal insulin secretion and contribute to compensatory insulin hypersecretion during the development of diabetes in male mice. Endocrinology (2014) 0.83
Beta-cell function in mild type 2 diabetic patients: effects of 6-month glucose lowering with nateglinide. Diabetes Care (2005) 0.83
The impact of diabetes and diabetes medications on bone health. Endocr Rev (2015) 0.82
Insulin resistance increases PAI-1 in the heart. Biochem Biophys Res Commun (2006) 0.82
Associations of fatty acids in cerebrospinal fluid with peripheral glucose concentrations and energy metabolism. PLoS One (2012) 0.82
Increased plasminogen activator inhibitor type-1 (PAI-1) in the heart as a function of age. Life Sci (2006) 0.81
Efficacy and safety of incretin-based therapies in patients with type 2 diabetes mellitus. Eur J Intern Med (2009) 0.81
GIP: an inconsequential incretin or not? Diabetes Care (2010) 0.80
Abdominal obesity and cardiovascular disease risk: the emerging role of the adipocyte. J Cardiopulm Rehabil Prev (2007) 0.80
The PROactive Study: pioglitazone in the secondary prevention of macrovascular events in patients with type 2 diabetes. Curr Diab Rep (2006) 0.80
Liraglutide achieves A1C targets more often than sitagliptin or exenatide when added to metformin in patients with type 2 diabetes and a baseline A1C <8.0%. Endocr Pract (2013) 0.80
COMPARISON OF THE LONG-TERM EFFECTS OF LIRAGLUTIDE AND GLIMEPIRIDE MONOTHERAPY ON BONE MINERAL DENSITY IN PATIENTS WITH TYPE 2 DIABETES. Endocr Pract (2015) 0.78
UCP5/BMCP1 transcript isoforms in human skeletal muscle: relationship of the short-insert isoform with lipid oxidation and resting metabolic rates. Mol Genet Metab (2002) 0.77
Efficacy of antihyperglycemic therapies and the influence of baseline hemoglobin A(1C): a meta-analysis of the liraglutide development program. Endocr Pract (2011) 0.77
The quality of fat in the diet and its impact on insulin sensitivity. Curr Diab Rep (2002) 0.76
LAP-BAND or medical therapy for metabolic syndrome? Curr Diab Rep (2008) 0.75
Does the metabolic syndrome carry additional risk for myocardial infarction? Curr Diab Rep (2011) 0.75
Effects of improving insulin sensitivity on nontraditional cardiovascular risk factors in patients with type 2 diabetes. Curr Diab Rep (2003) 0.75
The DREAM Trial: using ramipril and rosiglitazone to prevent diabetes. Curr Diab Rep (2007) 0.75
Beta-cell preservation…Is weight loss the answer? Rev Diabet Stud (2012) 0.75
Weight loss and diets: which diet works best? Curr Diab Rep (2009) 0.75
On rendering continuous glucose monitoring ready for prime time in the cardiac care unit. Coron Artery Dis (2007) 0.75